Case Report: Good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma
Conclusions: This case provided evidence of Toripalimab combined with chemotherapy on melanoma patients with complex cardiovascular diseases. Toripalimab demonstrated a manageable safety profile and durable clinical response. In addition, the standard CHF treatment plays a vital role in the protection of cardiac function. In a cancer patient with complex cardiovascular diseases, standard prophylactic CHF treatment should be applied at an early stage.PMID:35979233 | PMC:PMC9376878 | DOI:10.3389/fphar.2022.890546
Source: Cancer Control - Category: Cancer & Oncology Authors: Wei Pan Li Yin Yadi Guo Dachao Pan Hui Huang Source Type: research
More News: Bisoprolol | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | China Health | Diovan | Genetics | Heart | Immunotherapy | Melanoma | Oral Cancer | Skin Cancer | Spironolactone | Toxicology